Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesOrthopedics/MusculoskeletalRegence Laser Discectomy Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentRegence BlueCross BlueShieldPolicy 131

    Decompression of Intervertebral Discs Using Laser Energy (Laser Discectomy) or Radiofrequency Energy (Nucleoplasty)

    Customize your policy alerts

    Sign up for regence Policy 131 alerts

    Get alerted when Policy 131 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage of intervertebral disc decompression using laser or radiofrequency energy, including laser discectomy, disc nucleoplasty, and related adjunctive chemonucleolysis.

    Policy Summary
    PayerRegence BlueCross BlueShield
    PolicyLaser Discectomy and Disc Nucleoplasty
    Policy CodePolicy 131
    Change TypeNo material change
    Effective DateNovember 1, 2026
    Last ReviewSep 1, 2026
    Next Review DateJuly 1, 2027
    Key ActionDo not seek coverage for laser discectomy, radiofrequency disc nucleoplasty, or adjunctive chemonucleolysis because these procedures are investigational for all indications.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    InvestigationalLaser discectomy and radiofrequency coblation
    2Primary procedures addressed
    40%Maximum reported reoperation rate
    InvestigationalCoverage status

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    July 2027
    Next policy review

    Coverage Criteria

    Laser discectomy and disc nucleoplasty

    The following procedures are considered investigational for all indications.

    Laser discectomy and radiofrequency coblation (disc nucleoplasty) are considered investigational for all indications, including but not limited to disc decompression and treatment of associated pain.

    Adjunctive chemonucleolysis

    The following adjunctive procedure is considered investigational.

    Adjunctive chemonucleolysis: Chemonucleolysis as an adjunct to percutaneous disc decompression procedures, including but not limited to disc nucleoplasty, is considered investigational.

    Laser discectomy, radiofrequency nucleoplasty, and adjunctive chemonucleolysis

    These procedures are considered investigational for any indication.

    Investigational procedures: Laser discectomy and radiofrequency disc nucleoplasty for disc decompression, with or without chemonucleolysis, are considered investigational because available research is insufficient to show improved health outcomes for people with any indication, including disc decompression and treatment of associated pain.

    Chemonucleolysis as an adjunct to percutaneous disc decompression procedures, including disc nucleoplasty, is also investigational.

    This policy does not address intradiscal electrothermal annuloplasty (IDET), percutaneous intradiscal radiofrequency thermocoagulation (PIRFT), or percutaneous and endoscopic discectomy. These services are considered under separate medical policies.

    Coding Information

    Experimental CPT CodesCPTExperimental
    62287Decompression, percutaneous, of nucleus pulposus of intervertebral disc, any method utilizing needle based technique to remove disc material under fluoroscopic imaging or other form of indirect visualization, with discography and/or epidural injection(s) at the treated level(s), when performed, single or multiple levels, lumbar.
    62292Injection procedure for chemonucleolysis including discography, intervertebral disc, single or multiple levels, lumbar.
    Experimental HCPCS CodesHCPCSExperimental
    S2348Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar

    Provider and Billing Actions

    Denial Risk

    Laser or radiofrequency disc decompression is investigational

    Coverage is denied because laser discectomy and radiofrequency coblation (disc nucleoplasty) are considered investigational for all indications, including disc decompression and treatment of associated pain.

    Denial Risk

    Do not use adjunctive chemonucleolysis

    Coverage is denied when chemonucleolysis is performed as an adjunct to percutaneous disc decompression procedures, including disc nucleoplasty, because the adjunct is considered investigational.

    Denial Risk

    Investigational for any indication

    Laser discectomy and radiofrequency disc nucleoplasty for disc decompression, with or without chemonucleolysis, are considered investigational for any indication, including treatment of disc-related pain. Available research is insufficient to show improved health outcomes.

    Clinical Background

    Laser discectomy delivers laser energy through a needle or catheter under fluoroscopic guidance to vaporize or ablate nucleus pulposus tissue. Disc nucleoplasty, also called radiofrequency coblation, uses bipolar radiofrequency energy to create small channels through localized ablation of disc tissue. Chemonucleolysis involves injecting chymopapain into a ruptured or bulging disc to dissolve disc material and is addressed in this policy as an adjunct to percutaneous disc decompression. Although these procedures have been described for conditions such as bulging discs and sciatica, the available evidence is limited and does not establish improved outcomes compared with conventional surgical decompression; the policy considers laser discectomy and disc nucleoplasty investigational for all indications.

    Procedure Definitions

    Laser discectomy
    Energy sourceLaser energy
    Delivery methodDelivered via a needle or catheter inserted into the disc nucleus under fluoroscopic guidance
    Procedural actionVaporization, ablation, or coagulation of disc tissue
    Treatment patternThe laser is typically activated for brief periods; protocols vary according to treatment length
    Disc nucleoplasty
    Energy sourceBipolar radiofrequency energy
    Ablation methodSmall, multiple electrodes direct energy into the disc to ablate disc tissue through a low-temperature plasma field of ionized particles
    Policy Summary
    PayerRegence BlueCross BlueShield
    PolicyLaser Discectomy and Disc Nucleoplasty
    Policy CodePolicy 131
    Change TypeNo material change
    Effective DateNovember 1, 2026
    Last ReviewSep 1, 2026
    Next Review DateJuly 1, 2027
    Key ActionDo not seek coverage for laser discectomy, radiofrequency disc nucleoplasty, or adjunctive chemonucleolysis because these procedures are investigational for all indications.
    SourceLink
    On This Page
    Coverage CriteriaCoding InformationProvider and Billing ActionsClinical BackgroundProcedure Definitions
    Tissue effectThe plasma-field particles break organic molecular bonds within tissue, creating small channels in the disc
    Alternative namesAlso called disc nucleoplasty or coblation
    Chemonucleolysis
    Substance usedChymopapain, a protein-dissolving enzyme derived from papaya
    AdministrationInjected into a ruptured or bulging disc
    Procedural actionAblates or dissolves disc material
    Use addressed by this policyProposed as a pretreatment or adjunct to percutaneous disc decompression procedures, including disc nucleoplasty